Post-induction treatment for acute myeloid leukemia: something change?
Until recently, improvement in terms of survival for patients with acute myeloid leukemia (AML) was achieved mostly in younger patients with dose intensification of conventional chemotherapy and a broadening use of allogeneic hematopoietic cell transplantation (allo-HCT) whereas the results remained...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
16 July 2021
|
| In: |
Current oncology reports
Year: 2021, Jahrgang: 23, Heft: 9 |
| ISSN: | 1534-6269 |
| DOI: | 10.1007/s11912-021-01092-0 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s11912-021-01092-0
|
| Verfasserangaben: | Sonia Jaramillo, Richard F. Schlenk |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1771701609 | ||
| 003 | DE-627 | ||
| 005 | 20230427130224.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210923s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11912-021-01092-0 |2 doi | |
| 035 | |a (DE-627)1771701609 | ||
| 035 | |a (DE-599)KXP1771701609 | ||
| 035 | |a (OCoLC)1341421145 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Jaramillo Segura, Sonia |e VerfasserIn |0 (DE-588)1149855606 |0 (DE-627)1010162772 |0 (DE-576)496412213 |4 aut | |
| 245 | 1 | 0 | |a Post-induction treatment for acute myeloid leukemia: something change? |c Sonia Jaramillo, Richard F. Schlenk |
| 264 | 1 | |c 16 July 2021 | |
| 300 | |a 1-10$t10 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 23.09.2021 | ||
| 520 | |a Until recently, improvement in terms of survival for patients with acute myeloid leukemia (AML) was achieved mostly in younger patients with dose intensification of conventional chemotherapy and a broadening use of allogeneic hematopoietic cell transplantation (allo-HCT) whereas the results remained dismal and very stable in patients older than 60 years. The current review highlights the recent developments in standard intensive post-remission chemotherapy, evidence for the use of recently approved agents, and discusses the relevance of measurable residual disease (MRD) measurement in treatment adaptation. | ||
| 700 | 1 | |a Schlenk, Richard Friedrich |d 1965- |e VerfasserIn |0 (DE-588)129025380 |0 (DE-627)387778004 |0 (DE-576)297454102 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Current oncology reports |d Philadelphia, Pa. : Current Science, Inc., 1999 |g 23(2021), 9, Artikel-ID 109 |h Online-Ressource |w (DE-627)332626490 |w (DE-600)2054295-1 |w (DE-576)288574044 |x 1534-6269 |7 nnas |a Post-induction treatment for acute myeloid leukemia: something change? |
| 773 | 1 | 8 | |g volume:23 |g year:2021 |g number:9 |g elocationid:109 |g extent:1-10$t10 |a Post-induction treatment for acute myeloid leukemia: something change? |
| 856 | 4 | 0 | |u https://doi.org/10.1007/s11912-021-01092-0 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210923 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 129025380 |a Schlenk, Richard Friedrich |m 129025380:Schlenk, Richard Friedrich |d 910000 |d 910100 |e 910000PS129025380 |e 910100PS129025380 |k 0/910000/ |k 1/910000/910100/ |p 2 |y j | ||
| 998 | |g 1149855606 |a Jaramillo Segura, Sonia |m 1149855606:Jaramillo Segura, Sonia |d 910000 |d 910100 |e 910000PJ1149855606 |e 910100PJ1149855606 |k 0/910000/ |k 1/910000/910100/ |p 1 |x j | ||
| 999 | |a KXP-PPN1771701609 |e 3980673111 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"title":[{"title":"Post-induction treatment for acute myeloid leukemia: something change?","title_sort":"Post-induction treatment for acute myeloid leukemia: something change?"}],"person":[{"given":"Sonia","family":"Jaramillo Segura","role":"aut","display":"Jaramillo Segura, Sonia","roleDisplay":"VerfasserIn"},{"given":"Richard Friedrich","family":"Schlenk","role":"aut","display":"Schlenk, Richard Friedrich","roleDisplay":"VerfasserIn"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 23.09.2021"],"language":["eng"],"recId":"1771701609","origin":[{"dateIssuedDisp":"16 July 2021","dateIssuedKey":"2021"}],"id":{"eki":["1771701609"],"doi":["10.1007/s11912-021-01092-0"]},"name":{"displayForm":["Sonia Jaramillo, Richard F. Schlenk"]},"physDesc":[{"extent":"1-10$t10 S."}],"relHost":[{"origin":[{"publisher":"Current Science, Inc.","dateIssuedKey":"1999","dateIssuedDisp":"1999-","publisherPlace":"Philadelphia, Pa."}],"id":{"zdb":["2054295-1"],"eki":["332626490"],"issn":["1534-6269"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Current oncology reports","title_sort":"Current oncology reports"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 30.10.13"],"disp":"Post-induction treatment for acute myeloid leukemia: something change?Current oncology reports","language":["eng"],"recId":"332626490","pubHistory":["1.1999 -"],"part":{"extent":"1-10$t10","text":"23(2021), 9, Artikel-ID 109","volume":"23","issue":"9","year":"2021"}}]} | ||
| SRT | |a JARAMILLOSPOSTINDUCT1620 | ||